BB-kb@ldeleger:BB-kb-15293611 JSONTXT

Annnotations TAB TSV DIC JSON TextAE

Below, discontinuous spans are shown in the bag model. You can change it to the chain model.

Id Subject Object Predicate Lexical cue NCBI_Taxonomy OntoBiotope
T1 0-87 Title denotes Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units.
T3 18-40 Microorganism denotes Pseudomonas aeruginosa 287
E1 18-40 Lives_In denotes Pseudomonas aeruginosa
E2 18-40 Lives_In denotes Pseudomonas aeruginosa
T5 44-54 Habitat denotes paediatric OBT:003188
T7 59-64 Habitat denotes adult OBT:003245
T6 59-86 Habitat denotes adult cystic fibrosis units OBT:000097
T4-1 44-54,65-86 Habitat denotes paediatric cystic fibrosis units
T2 88-1551 Paragraph denotes Despite recent reports of clonal strains of Pseudomonas aeruginosa in cystic fibrosis (CF) units, the need for routine microbiological surveillance remains contentious. Sputum was collected prospectively from productive patients attending the regional paediatric and adult CF units in Brisbane, Australia. All P. aeruginosa isolates were typed using pulsed-field gel electrophoresis. Spirometry, anthropometrics, hospitalisations and antibiotic sensitivity data were recorded. The first 100 sputum samples (first 50 patients at each clinic) harboured 163 isolates of P. aeruginosa. A total of 39 patients shared a common strain (pulsotype 2), 20 patients shared a strain with at least one other patient and 41 patients harboured unique strains. Eight patients shared a strain identical to a previously reported Australian transmissible strain (pulsotype 1). Compared with the unique strain group, patients harbouring pulsotype 2 were younger and had poorer lung function. Treatment requirements were similar in these two groups, as were the rates of multiresistance. In conclusion, 59% of patients harboured a clonal strain, supporting the need for routine microbiological surveillance. In contrast to previously described clonal strains, the dominant pulsotype was indistinguishable from nonclonal strains with respect to both colonial morphology and multiresistance. The clinical significance of clonal strains remains uncertain and requires longitudinal study.
T8 132-154 Microorganism denotes Pseudomonas aeruginosa 287
E3 132-154 Lives_In denotes Pseudomonas aeruginosa
T9 158-184 Habitat denotes cystic fibrosis (CF) units OBT:000097
T10 257-263 Habitat denotes Sputum OBT:001335
T11 297-316 Habitat denotes productive patients OBT:003220
T14 340-350 Habitat denotes paediatric OBT:003188
T15 355-360 Habitat denotes adult OBT:003245
T12-1 331-339,355-369 Habitat denotes regional adult CF units
T13-1 331-350,361-369 Habitat denotes regional paediatric CF units
T16 398-411 Microorganism denotes P. aeruginosa 287
E4 398-411 Lives_In denotes P. aeruginosa
E5 398-411 Lives_In denotes P. aeruginosa
T17 522-544 Phenotype denotes antibiotic sensitivity OBT:002675
T18 579-585 Habitat denotes sputum OBT:001335
T19 604-612 Habitat denotes patients OBT:003220
T20 621-627 Habitat denotes clinic OBT:002694
T21 655-668 Microorganism denotes P. aeruginosa 287
E8 655-668 Lives_In denotes P. aeruginosa
E9 655-668 Lives_In denotes P. aeruginosa
E10 655-668 Lives_In denotes P. aeruginosa
E11 655-668 Lives_In denotes P. aeruginosa
E12 655-668 Lives_In denotes P. aeruginosa
E13 655-668 Lives_In denotes P. aeruginosa
E14 655-668 Lives_In denotes P. aeruginosa
E15 655-668 Lives_In denotes P. aeruginosa
E16 655-668 Lives_In denotes P. aeruginosa
E17 655-668 Exhibits denotes P. aeruginosa
T22 684-692 Habitat denotes patients OBT:003220
T23 734-742 Habitat denotes patients OBT:003220
T24 783-790 Habitat denotes patient OBT:003220
T25 798-806 Habitat denotes patients OBT:003220
T26 839-847 Habitat denotes patients OBT:003220
T27 985-993 Habitat denotes patients OBT:003220
T28 1045-1049 Habitat denotes lung OBT:000716
T29 1138-1153 Phenotype denotes multiresistance OBT:002674
T30 1177-1185 Habitat denotes patients OBT:003220
T31 1416-1435 Phenotype denotes colonial morphology OBT:000064
T32 1440-1455 Phenotype denotes multiresistance OBT:002674
R1 E1 T3 Microorganism Pseudomonas aeruginosa,Pseudomonas aeruginosa
R10 E5 T10 Location P. aeruginosa,Sputum
R11 E8 T21 Microorganism P. aeruginosa,P. aeruginosa
R12 E8 T22 Location P. aeruginosa,patients
R13 E9 T21 Microorganism P. aeruginosa,P. aeruginosa
R14 E9 T26 Location P. aeruginosa,patients
R15 E10 T21 Microorganism P. aeruginosa,P. aeruginosa
R16 E10 T24 Location P. aeruginosa,patient
R17 E11 T21 Microorganism P. aeruginosa,P. aeruginosa
R18 E11 T30 Location P. aeruginosa,patients
R19 E12 T21 Microorganism P. aeruginosa,P. aeruginosa
R2 E1 T6 Location Pseudomonas aeruginosa,adult cystic fibrosis units
R20 E12 T23 Location P. aeruginosa,patients
R21 E13 T21 Microorganism P. aeruginosa,P. aeruginosa
R22 E13 T18 Location P. aeruginosa,sputum
R23 E14 T21 Microorganism P. aeruginosa,P. aeruginosa
R24 E14 T27 Location P. aeruginosa,patients
R25 E15 T21 Microorganism P. aeruginosa,P. aeruginosa
R26 E15 T19 Location P. aeruginosa,patients
R27 E16 T21 Microorganism P. aeruginosa,P. aeruginosa
R28 E16 T25 Location P. aeruginosa,patients
R29 E17 T21 Microorganism P. aeruginosa,P. aeruginosa
R3 E2 T3 Microorganism Pseudomonas aeruginosa,Pseudomonas aeruginosa
R30 E17 T29 Property P. aeruginosa,multiresistance
R4 E2 T4-0 Location Pseudomonas aeruginosa,
R5 E3 T8 Microorganism Pseudomonas aeruginosa,Pseudomonas aeruginosa
R6 E3 T9 Location Pseudomonas aeruginosa,cystic fibrosis (CF) units
R7 E4 T16 Microorganism P. aeruginosa,P. aeruginosa
R8 E4 T11 Location P. aeruginosa,productive patients
R9 E5 T16 Microorganism P. aeruginosa,P. aeruginosa